Automation in Biopharma Industry Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology, By Application, by Component, By Region & Competition, 2020-2030F
상품코드:1691793
리서치사:TechSci Research
발행일:2025년 03월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계 바이오의약품 산업 자동화 시장은 2024년에 18억 9,430만 달러로 평가되었으며, 예측 기간중 CAGR은 6.63%를 나타낼 전망이며, 2030년까지는 27억 8,360만 달러에 이를 것으로 예측되고 있습니다.
바이오의약품(생물제약) 산업에서의 자동화는 첨단 기술, 시스템, 프로세스를 사용하여 인간의 개입을 최소화하면서 다양한 작업, 실험 및 제조 공정를 수행하는 것을 말합니다. 바이오 의약품 산업에서 자동화의 주요 목표는 연구, 개발, 제조 활동에서 효율성, 정확성, 일관성 및 안전성을 향상시키는 것입니다. 바이오 의약품 제조에서 공정 자동화는 매우 중요합니다. 이것은 세포 배양, 발효, 정제, 충전 마감 작업 등의 작업에 자동화 시스템과 장비를 사용하는 것입니다. 공정 자동화는 제품의 품질과 일관성을 유지하기 위한 중요한 파라미터(온도, pH, 교반 등)의 정확한 제어를 보장합니다. 로봇 시스템은 신약과 시료의 취급에서부터 제조에 있어서의 충전이나 포장에 이르기까지, 폭넓은 작업에 채용되고 있습니다. 로봇은 시료, 시약, 실험 기구의 취급을 프로그래밍할 수 있으며 정확하고 재현성 있는 작업을 수행합니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
18억 9,430만 달러
시장 규모 : 2030년
27억 8,360만 달러
CAGR : 2025년-2030년
6.63%
급성장 부문
디지털화 기술
최대 시장
북미
주요 시장 성장 촉진요인
기술 진보
주요 시장 과제
도입 비용
주요 시장 동향
실험실 자동화
목차
제1장 제품 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 세계의 바이오의약품 산업 자동화 시장 전망
시장 규모와 예측
금액별
시장 점유율 및 예측
기술별(자동화 기술, 디지털화 기술)
용도별(임상단계, 신약단계, 생산단계)
구성 요소별(자동화 하드웨어, 자동화 소프트웨어, 서비스 프로젝트 단계, 서비스 운영 단계)
지역별
기업별(2024년)
시장 맵
제6장 아시아태평양의 바이오의약품 산업 자동화 시장 전망
시장 규모와 예측
시장 점유율 및 예측
아시아태평양 : 국가별 분석
인도
호주
일본
한국
제7장 유럽의 바이오의약품 산업 자동화 시장 전망
시장 규모와 예측
시장 점유율 및 예측
유럽 : 국가별 분석
독일
스페인
이탈리아
영국
제8장 북미의 바이오의약품 산업 자동화 시장 전망
시장 규모와 예측
시장 점유율 및 예측
북미 : 국가별 분석
멕시코
캐나다
제9장 남미의 바이오의약품 산업 자동화 시장 전망
시장 규모와 예측
시장 점유율 및 예측
남미 : 국가별 분석
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 바이오의약품 산업 자동화 시장 전망
시장 규모와 예측
시장 점유율 및 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트(UAE)
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
최근 동향
제품 출시
합병과 인수
제13장 세계의 바이오의약품 산업 자동화 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계 내 경쟁
신규 진입의 가능성
공급자의 힘
고객의 힘
대체품의 위협
제15장 PESTEL 분석
제16장 경쟁 구도
PerkinElmer Inc.
AMETEK, Inc.
Autodesk, Inc.
Baumueller-Nuermont Corp
Emerson Electric Co.
Kawasaki Robotics
Rheosense Inc.
Rockwell Automation Inc.
Sartorius Stedim Biotech SA
Siemens Healthineers
제17장 전략적 제안
제18장 기업 소개와 면책사항
SHW
영문 목차
영문목차
Global Automation in Biopharma Industry Market was valued at USD 1894.3 million in 2024 and is expected to reach USD 2783.6 million by 2030 with a CAGR of 6.63% during the forecast period. Automation in the biopharmaceutical (biopharma) industry refers to the use of advanced technology, systems, and processes to perform various tasks, experiments, and manufacturing processes with minimal human intervention. The primary goals of automation in the biopharma industry are to improve efficiency, accuracy, consistency, and safety in research, development, and manufacturing activities. In biopharmaceutical manufacturing, process automation is crucial. It involves the use of automated systems and instruments for tasks such as cell culture, fermentation, purification, and fill-finish operations. Process automation ensures the precise control of critical parameters (e.g., temperature, pH, and agitation) to maintain product quality and consistency. Robotic systems are employed for a wide range of tasks, from drug discovery and sample handling to filling and packaging in manufacturing. Robots can be programmed to handle samples, reagents, and labware, performing tasks with precision and repeatability.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 1894.3 Million
Market Size 2030
USD 2783.6 Million
CAGR 2025-2030
6.63%
Fastest Growing Segment
Digitization Technology
Largest Market
North America
Key Market Drivers
Technological Advancements
Robotics and automation have become increasingly sophisticated, with the integration of advanced robotics in laboratories and production facilities. These robots can perform a wide range of tasks, from liquid handling and sample preparation to cell culture maintenance. Automation systems have improved the efficiency of High-Throughput Screening (HTS) in drug discovery. Automated liquid handling and data analysis tools allow for the rapid screening of thousands of compounds for potential drug candidates. Lab-on-a-Chip (LOC) Technology integrates various laboratory functions onto a single chip, reducing the need for manual interventions. This technology is particularly useful for sample preparation and analysis. Advancements in software and data analytics enable real-time monitoring and analysis of experimental data. This facilitates quicker decision-making in drug development and manufacturing processes. Artificial Intelligence (AI) and Machine Learning (ML) are being used for data analysis, predictive modeling, and optimization of bioprocessing. They can help identify potential drug candidates and optimize manufacturing processes.
Key Market Challenges
Cost of Implementation
The purchase of automation equipment, software, and related technologies requires a substantial capital investment. This includes the costs of acquiring hardware, robotics, sensors, and other automation components. Tailoring automation systems to the specific needs of biopharmaceutical processes often involves customization. Custom solutions are typically more expensive than off-the-shelf products. Integrating automation systems with existing processes and infrastructure can be complex and costly. Compatibility and interoperability with legacy systems may require additional investments. Ensuring that automation systems meet regulatory standards and industry-specific validation requirements adds to the cost. Extensive testing, documentation, and validation processes are necessary to ensure compliance. Employees must be trained to operate and maintain automation systems effectively. Training programs come with associated costs, including staff time and external training resources. Automation systems require ongoing maintenance and technical support. This includes software updates, equipment maintenance, and troubleshooting, all of which have associated costs.
Key Market Trends
Lab Automation
Lab automation systems enable high-throughput screening of compounds, allowing researchers to quickly test many potential drug candidates. This is essential in the early stages of drug discovery. Automation systems in the lab provide precise and accurate handling of samples, reducing the risk of human error and ensuring consistent and reliable results. Automation simplifies data collection, storage, and analysis. It enables real-time monitoring and data processing, facilitating faster decision-making in research and development. Automated processes are more efficient and can run continuously, reducing the time and effort required for experiments and assays. This accelerates research and development timelines. Automation reduces the need for manual labor in repetitive and time-consuming tasks, resulting in cost savings and the redeployment of human resources to more strategic activities. Automation optimizes the use of resources, such as reagents, consumables, and equipment, making laboratory operations more cost-effective.
ABB Robotics will return for a second year to the Society for Laboratory Automation and Screening (SLAS) 2025 International Conference & Exhibition, January 25-29 at the San Diego Convention Center (Booth #2541). Highlights of ABB's participation include two live robotic automation demos and a roundtable discussion with industry leaders, including METTLER TOLEDO and Agilent Technologies, to explore the challenges laboratories face and how robotics can help, on January 28.
Key Market Players
PerkinElmer, Inc.
AMETEK, Inc.
Autodesk, Inc.
Baumueller-Nuermont Corp
Emerson Electric Co.
Kawasaki Robotics
RheoSense Inc.
Rockwell Automation, Inc.
Sartorius Stedim Biotech SA
Siemens Healthineers
Report Scope:
In this report, the Global Automation in Biopharma Industry Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Automation in Biopharma Industry Market, By Technology:
Automation Technology
Digitization Technology
Automation in Biopharma Industry Market, By Application:
Clinical Phase
Drug Discovery Phase
Production Phase
Automation in Biopharma Industry Market, By Component:
Automation Hardware
Automation Software
Services Project Phase
Services Operation Phase
Automation in Biopharma Industry Market, By Region:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
South Korea
Australia
Japan
Europe
Germany
France
United Kingdom
Spain
Italy
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Automation in Biopharma Industry Market.
Available Customizations:
Global Automation in Biopharma Industry Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Applications
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Automation in Biopharma Industry Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Technology (Automation Technology, Digitization Technology)
5.2.2. By Application (Clinical Phase, Drug Discovery Phase, Production Phase)
